Speciality: Hematology
Description:
Welcome to our podcast on Diagnosis and Management in Hematology. Hematology is the study of blood and blood disorders, and accurate diagnosis is the first step towards effective treatment. Common diagnostic tools include complete blood counts, peripheral blood smears, bone marrow biopsies, and advanced molecular tests. Once a diagnosis is confirmed, management strategies depend on the specific condition—ranging from supportive care, such as transfusions, to targeted therapies like chemotherapy or immunotherapy. Early detection and a multidisciplinary approach are crucial for improving patient outcomes. Stay tuned as we explore the latest advancements and best practices in hematology, helping clinicians deliver optimal care for their patients.
See More Webinars @ Hidoc Webinars
1.
Why alarm is easing over a rise in pancreatic cancer among the young
2.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
3.
Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts
4.
Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology
5.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
4.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation